Melatonin for disordered sleep in individuals with autism spectrum disorders: Systematic review and discussion - 22/10/11
, Roger Godbout b, h
, Alain Nicolas c, i
, Patricia Franco d, j
, Bruno Claustrat e, k
, Jean-Marc Baleyte f, g, l 
Summary |
Sleep disturbance is common in autism spectrum disorders (ASD) and melatonin is widely prescribed in such cases despite a lack of guidelines. The aim of this paper is to provide a systematic review of efficacy and safety of exogenous melatonin for treating disordered sleep in individuals with ASD. We performed a Pubmed® documentary search enlarged by a manual review of references, which finally supplied 12 citations (4 case reports, 3 retrospective studies, 2 open-label clinical trials, and 3 placebo-controlled trials). As a whole, we found that the literature supports the existence of a beneficial effect of melatonin on sleep in individuals with ASD, with only few and minor side effects. However, considering the small number of studies and their methodological limits, these conclusions cannot yet be regarded as evidence-based. Randomized controlled trials and long-term follow-up data are still lacking to better assess efficacy and safety of exogenous melatonin for disordered sleep in individuals with ASD.
Le texte complet de cet article est disponible en PDF.Keywords : Asperger syndrome, Autistic disorder, Child development disorder, pervasive, Circadian rhythm, Drug chronotherapy, Hypnotics and sedatives, Melatonin, Sleep, Sleep initiation and maintenance disorders
Abbreviations : AA, AD, AS, ASD, CR, IR, PDDNOS
Plan
Vol 15 - N° 6
P. 379-387 - décembre 2011 Retour au numéroBienvenue sur EM-consulte, la référence des professionnels de santé.
L’accès au texte intégral de cet article nécessite un abonnement.
Déjà abonné à cette revue ?
